Sareum achieves mileston in Schering collaboration
Sareum Holdings plc announced the achievement of key success milestones in its collaboration with Schering AG. In this collaboration, first announced in October 2005, Sareum has succeeded in using X-ray crystallography to determine, on schedule, the three-dimensional structure of one of Schering's drug discovery research targets. According to the company, Sareum is the only organization to have successfully determined the structure of this target. As a result of this achievement, Sareum has received success milestone payments. Sareum will continue to provide structure information to support Schering's drug discovery research on this target in return for further success milestone payments.
Financial terms of the agreement were not disclosed.
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.